0001209191-23-039495.txt : 20230623
0001209191-23-039495.hdr.sgml : 20230623
20230623175407
ACCESSION NUMBER: 0001209191-23-039495
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230615
FILED AS OF DATE: 20230623
DATE AS OF CHANGE: 20230623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sarena Francis Willard
CENTRAL INDEX KEY: 0001423786
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39488
FILM NUMBER: 231038953
MAIL ADDRESS:
STREET 1: C/O FIVE PRIME THERAPEUTICS, INC.
STREET 2: 2 CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apexigen, Inc.
CENTRAL INDEX KEY: 0001814140
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851260244
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 INDUSTRIAL ROAD, SUITE C
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650.931.6236
MAIL ADDRESS:
STREET 1: 900 INDUSTRIAL ROAD, SUITE C
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
FORMER COMPANY:
FORMER CONFORMED NAME: Brookline Capital Acquisition Corp.
DATE OF NAME CHANGE: 20200603
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-15
0
0001814140
Apexigen, Inc.
APGN
0001423786
Sarena Francis Willard
C/O APEXIGEN, INC.
900 INDUSTRIAL ROAD, SUITE C
SAN CARLOS
CA
94070
0
1
0
0
President and COO
0
Common Stock
2023-06-15
4
F
0
6917
0.4911
D
155419
D
The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units.
/s/ Francis Sarena
2023-06-23